WebJan 1, 2005 · The combination of gemcitabine and radiotherapy is a promising combined modality therapy. However, the clinical application of this combination has to be implemented carefully because of an increased toxicity to normal tissues. A body of experimental evidence shows that gemcitabine is a potent radiosensitizer in vitro and in … WebMay 17, 2010 · Adding gemcitabine (Gemzar) to concurrent radiotherapy and cisplatinum in invasive bladder cancer could preserve the organ even when the tumor has invaded the muscle, according to French researchers. In their pilot study, they sought to determine the maximum tolerated dose of gemcitabine to use with the gold standard of cisplatinum + …
Gemcitabine in cervical cancer - PubMed
WebJun 1, 2024 · Excessive toxicity has not been observed when Gemcitabine for injection is administered more than 7 days before or after radiation. Radiation recall has been … WebMar 14, 2024 · radiation treatment. Both men and women using gemcitabine should use effective birth control to prevent pregnancy. Gemcitabine can harm an unborn baby if the mother or father is using this medicine. If you are a woman, do not use gemcitabine if you are pregnant. You may need to have a negative pregnancy test before starting this … clock repairs stoke on trent
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in ...
WebOct 1, 2011 · A phase II trial of this novel gemcitabine-based chemoradiotherapy approach, at a radiation dose of 36 Gy in 2.4-Gy fractions, is recommended on the basis of tolerance, patterns of failure, and survival data. 299 Highly Influential View 6 … WebApr 9, 2024 · This study investigated the long-term results, failure patterns, and prognostic factors of patients with initially inoperable non-metastatic pancreatic cancer (PC) receiving definitive radiotherapy (RT). Between January 2016 and December 2024, a total of 168 non-metastatic PC patients, who were surgically unresectable or medically inoperable, were … WebApr 14, 2024 · Treatment options for advanced gallbladder cancer (GBC) are scarce and usually rely on cytotoxic chemotherapy, but the effectiveness of any regimen is limited and recurrence rates are high. Here, we investigated the molecular mechanisms of acquired resistance in GBC through the development and characterization of two gemcitabine … bochs general protection